Detalhe da pesquisa
1.
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Lancet
; 399(10319): 36-49, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34883053
2.
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Lancet
; 398(10303): 856-869, 2021 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370971
3.
Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study.
PLoS Med
; 18(10): e1003816, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637439
4.
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
Lancet
; 399(10321): 234-236, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34942101
5.
Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora's box?
BMC Infect Dis
; 18(1): 641, 2018 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30526531
6.
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
Lancet
; 397(10289): 2043-2046, 2021 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991480
7.
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.
Nat Med
; 29(1): 147-157, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36228659
8.
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
J Infect
; 86(6): 574-583, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37028454
9.
Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial.
Clin Transl Sci
; 15(2): 524-534, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670021
10.
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.
Lancet Respir Med
; 10(11): 1049-1060, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690076
11.
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study.
Elife
; 92020 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820721
12.
Nasally delivered SARS-CoV-2 vaccines: future promise and challenges.
Lancet Respir Med
; 11(12): 1038-1039, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979589
13.
[Reliability of Commercial Tests for Hepatitis C Virus]. / Confiabilidad de las Pruebas Comerciales para la detección del Virus de la Hepatitis C.
Rev Medica Hered
; 29(1): 60-63, 2018.
Artigo
em Espanhol
| MEDLINE | ID: mdl-29686475
14.
Constitutional law--legislative naiveté in involuntary sterilization laws.
Wake Forest Law Rev
; 12(4): 1064-81, 1976.
Artigo
em Inglês
| MEDLINE | ID: mdl-11664745